skip to primary navigationskip to content
 

Why Cambridge is a start-up city

last modified Mar 24, 2014 03:30 PM
'Why have so many tech firms originated in Cambridge?' is the question posed by the BBC in a feature on the city's success - and Stew McTavish and three ideaSpace members are helping provide the answers.

 

In a feature on the BBC website entitled Next Silicon Valleys: Why Cambridge is a start-up city, business reporter Katie Hope explores the reasons why so many tech firms have originated from Silicon Fen.

Explaining the role of ideaSpace in helping tech firms to get established, director Stew McTavish says: "What we're really trying to do is provide a focal point for the start-up community to gather in one place to increase the chances of serendipitous interaction."

He believes that the university's academic freedom helps commercially. "They're permitted to experiment and if they fail that's fine as well as long as they do it in the right sorts of ways."

Aqdot, based at ideaSpace City, was founded in 2010 and has created a "shrink wrap" technology which can encapsulate tiny droplets of active ingredients to be released precisely when needed.

"When you bring academia and industry together that's when you create exciting opportunities," says co-founder and chief scientific officer Dr Roger Coulston.

Damian Gardiner, co-founder of University of Cambridge spinout Ilumink, based at ideaSpace West, said he has benefited from his connection to the university. He received an enterprise scholarship from the Royal Academy of Engineering to help him develop his research in printable laser technology into a commercial product aimed at fighting fraud.

He says: "I wanted to see how technology could be taken from the lab and actually used in a real world, a product that would be useful to people."

Also featured in the BBC article is Cambridge Nanosystems, based at the West site, which has developed a machine to convert gas waste, such as methane or carbon dioxide, into different types of carbon including graphene.

Less than two years ago, Dr Krzysztof Koziol, a director of the firm, was a full-time academic - now he is juggling the start-up alongside his role as head of the electric carbon nanomaterials group at the university's Department of Material Science.

The feature article is based on a series of television interviews for the BBC's Next Silicon Valley series. To read the full article visit here.

RSS Feed Latest news

Spotlight on Mursla

Feb 03, 2019

Cancer is one of the most challenging global issues an entrepreneur could choose to tackle. But Pierre Arsène and Victor Serdio are doing just that with their company Mursla. Based at ideaSpace West, Mursla is developing a breakthrough technology for early cancer detection using liquid biopsies, offering a less invasive and more responsive approach to diagnosis, treatment and cure. To mark World Cancer Day on the 4th February, we asked Pierre to explain more about Mursla and the bold ideas and enthusiasm driving this bright company.

LESSONS FROM A FOUNDER: What's Your 2019 Startup Goal?

Jan 30, 2019

For many of us, a new year often starts with an optimistic resolution to change – join the gym, write a book, travel perhaps. But if you’re running a startup, January is a great time to assess your company’s development and set fresh goals for the coming year. We asked four founders at ideaSpace to reflect on progress and share their area of focus for 2019.

GeoSpock Lands £10 Million in Additional Funding 

Jan 09, 2019

ideaSpace alumni and extreme data specialists, GeoSpock, have secured an extra  £10 million in funding. The latest round was led by Cambridge Innovation Capital (CIC) jointly with Parkwalk Advisors and Japanese firms Global Brain and 31Ventures. Japanese data tech company KDDI Supership joined as a strategic investor. Investment was also secured from existing investor, Jonathan Milner.

A Breath Test Could Detect Early Cancer Signs

Jan 06, 2019

CRUK and ideaSpace City members, Owlstone Medical, have launched a new trial to discover whether it's possible to detect early stage cancer symptoms from a person's breath.

Petagene secure $2.1 Million in Funding 

Jan 03, 2019

2019 is off to a great start for the Petagene team who have been awarded $2.1 million in additional funding. The latest round was lead by U.S. venture firm Romulus Capital, with collaboration from other unnamed investors in London and Silicon Valley, bringing the total funding awarded to $3.2 million.

View all news